Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 7Unknown 4Terminated 3Withdrawn 2Recruiting 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 333Neoplasms 221Prostatic Neoplasms 197Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 135Pancreatic Neoplasms 118Colorectal Neoplasms 103Neoplasm Metastasis 100Carcinoma, Hepatocellular 96Leukemia, Myeloid, Acute 94Multiple Myeloma 91Brain Neoplasms 89Lymphoma 86Head and Neck Neoplasms 76Melanoma 73Ovarian Neoplasms 72Leukemia 71Leukemia, Lymphocytic, Chronic, B-Cell 69Glioblastoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Colonic Neoplasms 61Recurrence 59Lymphoma, Non-Hodgkin 54Rectal Neoplasms 50Hematologic Neoplasms 50Lymphoma, Follicular 49Glioma 49Squamous Cell Carcinoma of Head and Neck 47Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Renal Cell 47

Interventions

Doxycycline 1Acitretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Exanthema × Clear all
NCT00803842 2015-02-26

Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash

Northwestern University

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT01299220 2013-01-16

Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug)

University of Pittsburgh

Phase 4 Withdrawn

Exanthema, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡